For how we live.
Alpha-blockers ease symptoms within weeks; 5-alpha-reductase inhibitors shrink the gland over months. In a 3,047-man trial, combining them cut progression risk by 66%. Newer office procedures spare sexual function.
Young men are starting hair-loss drugs early and stacking them with dermarolling and oral minoxidil. Two drugs have decades of evidence; the trend's framing runs ahead of it.
A network meta-analysis of 24 randomised trials ranks oral dutasteride first on 24-week hair density. The adverse-effect literature behind these drugs is separately, and seriously, contested.